Cargando…

Psoriasis and Major Adverse Cardiovascular Events: A Systematic Review and Meta‐Analysis of Observational Studies

BACKGROUND: Psoriasis is a chronic inflammatory disease that may be associated with increased risk of cardiovascular events, including cardiovascular mortality, myocardial infarction, and stroke. METHODS AND RESULTS: We searched the MEDLINE, EMBASE, and Cochrane Central Register databases for releva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Armstrong, Ehrin J., Harskamp, Caitlin T., Armstrong, April W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647278/ https://www.ncbi.nlm.nih.gov/pubmed/23557749 http://dx.doi.org/10.1161/JAHA.113.000062

Ejemplares similares

The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies
por: Armstrong, A W, et al.
Publicado: (2012)

Adherence to Guideline‐Recommended Therapy Is Associated With Decreased Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients With Peripheral Arterial Disease
por: Armstrong, Ehrin J., et al.
Publicado: (2014)

An update on psoriasis and metabolic syndrome: A meta-analysis of observational studies
por: Singh, Sanminder, et al.
Publicado: (2017)

Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta‐analysis of randomized controlled trials
por: Rungapiromnan, W., et al.
Publicado: (2017)

Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review
por: Bosco, Elliott, et al.
Publicado: (2021)

Cannabis and adverse cardiovascular events: A systematic review and meta-analysis of observational studies
por: Theerasuwipakorn, Nonthikorn, et al.
Publicado: (2023)

How current biologic therapies affect the risk of major adverse cardiovascular events in patients with plaque psoriasis? A systematic review and meta-analysis of randomized controlled trials
por: Nartowicz, Sonia, et al.
Publicado: (2021)

Serum copper levels and risk of major adverse cardiovascular events: a systematic review and meta-analysis
por: Muñoz-Bravo, Carlos, et al.
Publicado: (2023)

Off-Label Biologic Regimens in Psoriasis: A Systematic Review of Efficacy and Safety of Dose Escalation, Reduction, and Interrupted Biologic Therapy
por: Brezinski, Elizabeth A., et al.
Publicado: (2012)

Remnant-Like Particle Cholesterol and the Risk of Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis
por: Yang, Jie, et al.
Publicado: (2022)

JAK Inhibitors: Treatment Efficacy and Safety Profile in Patients with Psoriasis
por: Hsu, Leeyen, et al.
Publicado: (2014)

Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis
por: Butalia, Sonia, et al.
Publicado: (2011)

Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis
por: Wu, Shunquan, et al.
Publicado: (2016)

Predicting major adverse cardiovascular events for secondary prevention: protocol for a systematic review and meta-analysis of risk prediction models
por: Akyea, Ralph K, et al.
Publicado: (2020)

Supera self-expanding stents for endovascular treatment of femoropopliteal disease: a review of the clinical evidence
por: Bishu, Kalkidan, et al.
Publicado: (2015)

Reduction of Major Adverse Cardiovascular Events (MACE) after Bariatric Surgery in Patients with Obesity and Cardiovascular Diseases: A Systematic Review and Meta-Analysis
por: Sutanto, Andryanto, et al.
Publicado: (2021)

Prognostic value of plasma von Willebrand factor levels in major adverse cardiovascular events: a systematic review and meta-analysis
por: Fan, Mengge, et al.
Publicado: (2020)

Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib
por: Kristensen, Lars E., et al.
Publicado: (2023)

A Clinician’s Guide to the Diagnosis and Treatment of Candidiasis in Patients with Psoriasis
por: Armstrong, April W., et al.
Publicado: (2016)

The potential impact of systemic anti-inflammatory therapies in psoriasis on major adverse cardiovascular events: a Korean nationwide cohort study
por: Hong, Joo Ran, et al.
Publicado: (2021)

Psoriasis Increased the Risk of Adverse Cardiovascular Outcomes: A New Systematic Review and Meta-Analysis of Cohort Study
por: Liu, Lu, et al.
Publicado: (2022)

Quality of Life and Work Productivity Impairment among Psoriasis Patients: Findings from the National Psoriasis Foundation Survey Data 2003–2011
por: Armstrong, April W., et al.
Publicado: (2012)

Managing Patients with Psoriatic Disease: The Diagnosis and Pharmacologic Treatment of Psoriatic Arthritis in Patients with Psoriasis
por: Mease, Philip J., et al.
Publicado: (2014)

Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective Studies
por: Heianza, Yoriko, et al.
Publicado: (2017)

Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis
por: D’Andrea, Elvira, et al.
Publicado: (2020)

A Systematic Review and Meta-Analysis of the Incidence and Risk Factors for Major Adverse Cardiovascular Events in Patients with Unrepaired Abdominal Aortic Aneurysms
por: Sharma, Chinmay, et al.
Publicado: (2023)

Prognostic value of high-sensitivity cardiac troponin for major adverse cardiovascular events in patients with diabetes: a systematic review and meta-analysis
por: Song, Tiange, et al.
Publicado: (2023)

Managing Patients With Psoriasis in the Busy Clinic: Practical Tips for Health Care Practitioners
por: Armstrong, April W., et al.
Publicado: (2015)

Adverse drug events observed with 150 mg versus 300 mg secukinumab for the treatment of moderate to severe plaque psoriasis: A systematic review and meta-analysis
por: Zhang, Li, et al.
Publicado: (2019)

Corrigendum: Psoriasis Increased the Risk of Adverse Cardiovascular Outcomes: A New Systematic Review and Meta-Analysis of Cohort Study
por: Liu, Lu, et al.
Publicado: (2022)

Coronary Artery Bypass Grafting Among Patients With Prior Percutaneous Coronary Interventions
por: Kahlon, Ravi S., et al.
Publicado: (2018)

Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
por: Mal, Kheraj, et al.
Publicado: (2020)

Prediabetes as a risk factor for major adverse cardiovascular events
por: Mando, Ramy, et al.
Publicado: (2021)

Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular Events
por: Gaist, David, et al.
Publicado: (2022)

Comparison of HEAR and HEART Scores for Major Adverse Cardiovascular Events
por: Uyan, Umut
Publicado: (2023)

Major adverse cardiovascular events and hyperuricemia during tuberculosis treatment
por: Shin, Hong-Joon, et al.
Publicado: (2023)

Observational Evidence for Unintentional Weight Loss in All-Cause Mortality and Major Cardiovascular Events: A Systematic Review and Meta-Analysis
por: De Stefani, Fernanda do Carmo, et al.
Publicado: (2018)

Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients
por: Peluso, Rosario, et al.
Publicado: (2018)

Major Adverse Cardiovascular Events and Mortality Prediction by Circulating GDF-15 in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
por: Xie, Suyi, et al.
Publicado: (2022)

Major adverse cardiac events and cardiovascular toxicity with PARP inhibitors-based therapy for solid tumors: a systematic review and safety meta-analysis
por: Palazzo, A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j7hhkses6atn68t35o0et08i43